jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritida, revmatoidní - imunosupresiva - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastická činidla - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
xaloptic 0,05mg/ml oční kapky, roztok
pharmaceutical works polpharma s.a., starogard gdaňski array - 12369 latanoprost - oční kapky, roztok - 0,05mg/ml - latanoprost
xaloptic combi 0,05mg/ml+5mg/ml oční kapky, roztok
pharmaceutical works polpharma s.a., starogard gdaňski array - 12369 latanoprost; 2696 timolol-maleinÁt - oční kapky, roztok - 0,05mg/ml+5mg/ml - timolol, kombinace
empelic 10mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 10mg - empagliflozin
empelic 25mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 25mg - empagliflozin
mibrex 10mg tvrdá tobolka
zaklady farmaceutyczne polpharma sa, starogard gdański array - 17116 rivaroxaban - tvrdá tobolka - 10mg - rivaroxaban
mibrex 15mg tvrdá tobolka
zaklady farmaceutyczne polpharma sa, starogard gdański array - 17116 rivaroxaban - tvrdá tobolka - 15mg - rivaroxaban
mibrex 20mg tvrdá tobolka
zaklady farmaceutyczne polpharma sa, starogard gdański array - 17116 rivaroxaban - tvrdá tobolka - 20mg - rivaroxaban
targretin
eisai gmbh - bexaroten - lymfom, t-buňka, kožní - antineoplastická činidla - targretin tobolky je indikován k léčbě kožních projevů pokročilém stádiu kožní t-buněčného lymfomu (ctcl) pacientů refrakterních nejméně jedné celkové léčbě.